326 related articles for article (PubMed ID: 8711305)
1. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
[TBL] [Abstract][Full Text] [Related]
2. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of testicular cancer: 10-year experience.
Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
[TBL] [Abstract][Full Text] [Related]
6. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
[TBL] [Abstract][Full Text] [Related]
7. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Fléchon A; Biron P; Philip I; Blay JY; Droz JP
Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
[TBL] [Abstract][Full Text] [Related]
8. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
9. Primary chemotherapy for stage 2 testis cancer.
Abratt RP; McAdam GL; Pontin AR; Barnes RD; Ball HS
S Afr J Surg; 1997 Nov; 35(4):203-5; discussion 205-6. PubMed ID: 9540399
[TBL] [Abstract][Full Text] [Related]
10. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
11. [Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
Bassoulet J; Raoul Y; Garetta L
Ann Urol (Paris); 1986; 20(1):35-42. PubMed ID: 2423016
[TBL] [Abstract][Full Text] [Related]
12. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
13. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
14. [The chemotherapy of nonseminomatous testicular tumors].
Tiuliandin SA; Bulanov AA; Titov DA; Sokolov AV; Sholokhov VN; Garin AM
Urol Nefrol (Mosk); 1996; (2):26-9. PubMed ID: 8677548
[TBL] [Abstract][Full Text] [Related]
15. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of stage I malignant non-seminoma tumors of the testis without systematic lumbo-aortic dissection. Results of a study begun 20 years ago. Apropos of 21 cases].
Aubert J; Bon D; Dore B; Irani J
Prog Urol; 1994 Jun; 4(3):349-56. PubMed ID: 7519099
[TBL] [Abstract][Full Text] [Related]
17. [Stage II non-seminoma cancer of the testis: combined treatment with surgery and chemotherapy].
Orlandi L; Van Cauwelaert R; Orlandi F; Vargas R; San Martín S; Arraztoa J
Actas Urol Esp; 1989; 13(1):53-5. PubMed ID: 2469300
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
[TBL] [Abstract][Full Text] [Related]
19. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
